ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

Generic: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

Glenmark Pharmaceuticals Inc.Manufacturer
ORALRoute
ASPIRINActive Substance
2019-05-24Original Approval

ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE is FDA application ANDA210318, sponsored by GLENMARK SPECLT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
FALL
558 reports
2
HYPOTENSION
543 reports
3
PAIN
528 reports
4
COGNITIVE DISORDER
507 reports
5
DEPRESSED LEVEL OF CONSCIOUSNESS
480 reports
6
BALANCE DISORDER
473 reports
7
CONSTIPATION
473 reports
8
ORTHOSTATIC HYPOTENSION
469 reports
9
SEDATION COMPLICATION
457 reports
10
BLOOD CALCIUM DECREASED
447 reports